COMP <GO>
CON vs UNH // EV/EBITDA & P/E VALUATION
Concentra Group Holdings Parent Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CON 7
— UNH 5
▲ EV/EBITDA & P/E VALUATION LEADER: CON
LAST: $41.25 (+1.63%) • MKT CAP: $5.26B
valuation
15.4x
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
valuation
16.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CON VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CON | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.57% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 11.47% | +8.23 | CON | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 15.4x | 16.4x | -1.05 | CON | /valuation <GO> |
| Free Cash Flow Yield | 3.75% | 6.48% | -2.73 | UNH | /fcf-yield <GO> |
| Operating Margin | 15.40% | 4.82% | +10.58 | CON | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 3.14% | +4.56 | CON | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 6.46% | +7.44 | CON | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.61% | 2.28% | -1.67 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.53 | 3.12 | -0.59 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.6 | 59.2 | +10.40 | CON | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.33 | +0.67 | CON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 17.1x | +9.41 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.26B | $368.83B | -$363.57B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CON REV | UNH REV | CON GROSS % | UNH GROSS % | CON FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.16B | $447.57B | — | 88.7% | $197.1M | $16.07B |
| FY 2024 | $1.90B | $400.28B | — | 88.3% | $210.3M | $20.70B |
| FY 2023 | $1.84B | $371.62B | — | 89.6% | $151.6M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CON // BETA 1.00
UNH // BETA 0.33